[HTML][HTML] Lotilaner ophthalmic solution 0.25%: first approval

YY Syed - Drugs, 2023 - Springer
Abstract Lotilaner ophthalmic solution 0.25%(XDEMVY™), a gamma-aminobutyric acid-
gated chloride channel (GABA-Cl) inhibitor selective for mites, is being developed by Tarsus …

[HTML][HTML] Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease

D Valdés-Arias, EVT Locatelli, PA Sepulveda-Beltran… - Drugs, 2024 - Springer
Dry eye disease (DED) can arise from a variety of factors, including inflammation,
meibomian gland dysfunction (MGD), and neurosensory abnormalities. Individuals with DED …

[HTML][HTML] The varied influence of ocular Demodex infestation on dry eye disease and meibomian gland dysfunction across different age groups

WJ Lee, M Kim, SH Lee, YS Chun, KW Kim - Scientific Reports, 2023 - nature.com
This study aimed to investigate the impact of ocular demodicosis on dry eye disease (DED)
and meibomian gland dysfunction (MGD) across different age populations: young (20 to< …

[HTML][HTML] Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta …

M Talha, MH Ali, E Fatima, A Nadeem, A Ahmed… - American Journal of …, 2024 - Elsevier
Purpose This review aims to assess the safety and efficacy of Lotilaner in the treatment of
Demodex Blepharitis. Design Systematic Review and Meta-Analysis Background Demodex …

Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials

SMM Akhtar, A Fareed, MS Asghar, M Mumtaz… - Contact Lens and …, 2024 - Elsevier
Purpose Demodex blepharitis, often overlooked in ocular surface disease, involves
Demodex mites, prevalent ectoparasites on human skin. Current treatments may not …

Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% in the Treatment of Demodex Blepharitis: A Systematic Review and Meta-Analysis

M Abo Zeid, A Elrosasy, AW Abbas… - Ocular Immunology …, 2024 - Taylor & Francis
Purpose To evaluate the safety and efficacy of Lotilaner ophthalmic solution 0.25% in the
treatment of demodex blepharitis. Methods PubMed, Web of Science, Scopus, and Embase …

[HTML][HTML] A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis

B Awan, M Elsaigh, A Tariq, M Badee, A Loomba… - Cureus, 2024 - ncbi.nlm.nih.gov
Demodex blepharitis is marked by an excessive presence of Demodex mites on the eyelids,
particularly in the lash follicles. While these microscopic mites are a natural component of …

“Demodicosis” Mimicking PreSeptal Cellulitis: Severe Periocular and Facial Inflammation Caused by “Normal” Skin Flora

GM Desire, AM Stagner, LW Lin… - Ophthalmic Plastic & …, 2024 - journals.lww.com
Due to their relatively high prevalence and commensalism, the pathogenicity of Demodex
mites has been debated. Recent data, however, show Demodex to be associated with skin …

Role of Topical 5-Fluorouracil in Demodex-Associated Blepharitis

MM Amer, JW Ho, D Theotoka, S Wall, A Galor… - Cornea, 2022 - journals.lww.com
Purpose: The aim of this study was to report clinical observations suggesting the efficacy of
topical 1% 5-fluorouracil (5-FU) in treating Demodex-associated blepharitis. Methods: An …

Blepharitis Preferred Practice Pattern®

A Lin, S Ahmad, G Amescua, AY Cheung… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Blepharitis Preferred Practice Pattern® Blepharitis Preferred Practice Pattern®
Ophthalmology. 2024 Feb 12:S0161-6420(24)00008-3. doi: 10.1016/j.ophtha.2023.12.036 …